Virpax Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Virpax Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Virpax Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.01M, a 66.5% increase year-over-year.
  • Virpax Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$13.2M, a 2.76% increase year-over-year.
  • Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$15.2M, a 29.8% increase from 2022.
  • Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21.7M, a 79.6% decline from 2021.
  • Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.1M, a 178% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.